SXTPW Latest Press Releases

-- December 11, 2025 --

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA Sales and Marketing in 2026 Globe Newswire 8:01 AM

-- November 21, 2025 --

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine Globe Newswire 8:01 AM

-- November 13, 2025 --

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results Globe Newswire 1:51 PM

-- October 15, 2025 --

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study Globe Newswire 7:14 AM

-- October 9, 2025 --

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study Globe Newswire 7:04 AM

-- September 3, 2025 --

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:02 AM

-- August 21, 2025 --

60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:31 AM

-- August 19, 2025 --

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis Globe Newswire 8:54 AM

-- August 13, 2025 --

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results Globe Newswire 4:14 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software